EichorEICHOR
Location: Mostar Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Mostar

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Pre
Phase 3 · GC2202 Study Site 703 · Grifols Therapeutics LLC · NCT05645107First-degree Ankle Sprains
Phase N/A · Rehabilitation Centre Život · Rehabilitation Centre Zivot · NCT06645262Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids
Phase 1/Phase 2 · University Clinical Hospital , Mostar · Shionogi · NCT05588323A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · Site 484 · Spyre Therapeutics, Inc. · NCT07012395Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Phase 3 · 843 University Clinical Hospital Mostar · Can-Fite BioPharma · NCT05201404Vitamin B12, Folic Acid and Vitamin D Status in Women of Reproductive Age
Phase N/A · University Clinical Hospital Mostar, Primary Health Care Cen · University of Mostar · NCT07100795A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · University Clinical Hospital Mostar, Clinic for Infectious D · SynAct Pharma Aps · NCT07633288Vitamin B12, Folic Acid, and Vitamin D Status in Women of Reproductive Age
Phase N/A · University Hospital Mostar · University of Mostar · NCT07099586Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2 · Site Number - 5401 · Immunovant Sciences GmbH · NCT07032662A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Phase 1 · University Clinical Hospital Mosta, Bijeli Brijeg bb · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT07130916
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.